Ms Nina Rodriguez and Dr Tatyana Kushner confirm that the 2023 EASL guidelines can help risk stratify patients with intrahepatic cholestasis of pregnancy.
EASL guideline ICP risk groups:
A – normal serum bile acids and liver enzymes
B – normal serum bile acids and elevated liver enzymes
C – elevated serum bile acids with or without elevated liver enzymes
This video offers subtitles in English, Portuguese, and Spanish, which can be enabled using the subtitle icon 
in the video player.
Meet the experts
Tatyana Kushner, MD, MSCE
Associate Professor, Division of Gastroenterology and Hepatology
Joint appointments in the Department of Obstetrics and Gynecology and the Department of Population Health Sciences,Weill Cornell Medicine, USA.
Tatyana Kushner has a clinical practice that encompasses the full spectrum of liver diseases, with a focus on providing care to women living with liver disease, including pregnancy-related liver conditions and reproductive health as it pertains to liver disease. Her research interests focus on delineating the influence of chronic liver disease (such as MASLD and viral hepatitis) on pregnancy outcomes, developing improved detection and management of liver diseases during pregnancy (such as cholestasis of pregnancy and other liver diseases in pregnancy), and improved understanding of the interaction of liver disease with pregnancy. Her work has been published in numerous gastroenterology and liver journals.
Disclosures
Nina Rodriguez
Student, Icahn School of Medicine at Mount Sinai, USA
Nina Rodriguez is currently pursuing a scholarly year dedicated to conducting clinical research in hepatology as well as working towards a master’s degree in clinical research. She is focused on liver diseases during pregnancy.
Disclosures
None to declare.
